无码不卡黑人与日本人丨强奷乱码中文字幕熟女一丨欧美亚洲一区二区三区丨日韩精品免费无码专区丨一本一道久久久a久久久精品蜜臀丨国产明星裸体无码xxxx视频丨国精产品69永久中国有限丨亚洲精品欧美综合四区丨黄色毛片基地丨亚洲视频你懂的丨麻豆性生活丨亚洲韩国精品丨69热国产视频丨亚洲精品午夜一区人人爽丨欧美视频a丨国产高清露脸孕妇系列丨亚洲黄色视屏丨精美欧美一区二区三区丨亚洲最色网站丨久久成人精品视频丨亚洲精品久久午夜麻豆丨欧美二区在线观看丨99久久久成人国产精品免费丨国产熟人av一二三区丨男女乱婬真视频

Output value of biomedical industry in SIP reaches RMB 90 billion in 2019

SIP started deployment for biomedical industry in 2007. Since then, the industry has maintained an annual growth of more than 20% in total output value, which reached RMB 90 billion last year. This has enabled SIP to rank among the country’s best clusters of biomedicine businesses. Statistics show that SIP recorded a long list of new drugs that received approvals last year for clinical trials, which account for 10% of the national total, and of them, new biological drugs developed in SIP accounted for 20% of the national total.[MORE]